Avanza Fonder Ab Exact Sciences Corp Transaction History
Avanza Fonder Ab
- $3.05 Trillion
- Q1 2025
A detailed history of Avanza Fonder Ab transactions in Exact Sciences Corp stock. As of the latest transaction made, Avanza Fonder Ab holds 13,535 shares of EXAS stock, worth $708,421. This represents 0.02% of its overall portfolio holdings.
Number of Shares
13,535
Previous 19,512
30.63%
Holding current value
$708,421
Previous $1.1 Billion
44.99%
% of portfolio
0.02%
Previous 0.03%
Shares
2 transactions
Others Institutions Holding EXAS
# of Institutions
645Shares Held
157MCall Options Held
1.74MPut Options Held
1.56M-
Capital World Investors Los Angeles, CA17.8MShares$933 Million0.13% of portfolio
-
Vanguard Group Inc Valley Forge, PA17.6MShares$923 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA12.5MShares$654 Million0.11% of portfolio
-
Black Rock Inc. New York, NY12.1MShares$632 Million0.01% of portfolio
-
State Street Corp Boston, MA6.61MShares$346 Million0.01% of portfolio
About EXACT SCIENCES CORP
- Ticker EXAS
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 176,960,000
- Market Cap $9.26B
- Description
- Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...